GenEng News  Jul 2  Comment 
Compugen today said clinical trials will be launched for a pair of its cancer immunotherapy candidates targeting advanced solid tumors —its lead immuno-oncology program targeting PVRIG, which had been in clinical hold since April, and another...
Benzinga  Jul 2  Comment 
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user! Alkermes Plc (NASDAQ: ALKS) stock was trading higher by 3 percent early Monday morning after...
GenEng News  Apr 2  Comment 
AstraZeneca’s MedImmune subsidiary has agreed to exclusively license and develop bispecific and multispecific immuno-oncology antibody products from Compugen’s pipeline, through a collaboration that Compugen said today could generate for it up...
SeekingAlpha  Feb 21  Comment 



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki